Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov error page displays a newer site revision identifier, changing from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check10 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden response.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error page, with a simple header and footer, replacing the expected study details. This indicates the study record is temporarily inaccessible rather than displaying its content.SummaryDifference19%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor maintenance release. This change updates the versioning information shown on the page but does not alter the study details or available actions.SummaryDifference0.1%

- Check74 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5, signaling a small version bump in the site's software. It does not modify the study details, eligibility criteria, or other substantive content.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a small internal update to the document version.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.